Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
06/2003
06/19/2003CA2469622A1 Substituted hydroxyethylamines
06/19/2003CA2469021A1 Process for the synthesis of chirally pure .beta.-amino-alcohols
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1319037A1 Method for applying polymeric lens coating
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003CN1425012A Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579871 Methods of using novel compounds as neuro-protective agents
06/17/2003US6579633 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines
06/12/2003WO2003048150A1 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases
06/12/2003WO2003048137A1 Metabotropic glutamate receptor-5 modulators
06/12/2003WO2003048136A1 Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003047572A1 Use of 1-phenyl-oxazolidine-2-one compounds as protease m inhibitors
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003047512A2 Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
06/12/2003WO2002064094A3 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/12/2003US20030109714 Transition metal mediated process
06/12/2003US20030109563 Combating nematodes characterized in that trifluorobutenes of the formula (I) are allowed to act on nematodes and/or their habitat.
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109525 Provides crystals including a thiazine oxazolidinone. Thiazine oxazolidinones are useful as antimicrobials including gram-positive aerobic bacteria such as multiply-resistant staphylococci and streptococci, gram-negative aerobic
06/12/2003US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2468067A1 Metabotropic glutamate receptor-5 modulators
06/12/2003CA2463794A1 Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
06/11/2003EP1317461A1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
06/11/2003EP1317460A1 Compounds containing oxazolidinone moiety and uses thereof
06/11/2003EP1317418A2 2-amino-2-alkyl-4 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423566A 体重增加抑制剂 Weight gain inhibitor
06/11/2003CN1422851A Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease
06/11/2003CN1422844A Intermediate for preparing substitated biphenyl oxazoline compounds
06/10/2003US6576779 Catalyst compositions and processes for olefin polymers and copolymers
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003045930A1 Therapeutic compounds
06/05/2003WO2003045929A1 Bicyclic derivative, process for producing the same, and use
06/05/2003WO2003045928A1 Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
06/05/2003WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
06/05/2003WO2003045901A2 Guanidine derivatives
06/05/2003WO2003045898A1 Prodrugs of excitatory amino acids
06/05/2003US20030105111 For use as fluorescence dyes and probes
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105062 Anti-bacterial agents based upon oxoanion binding
06/04/2003EP1316550A1 6-Acylamino-5-substituted-benzoxazol-2-one compounds and method for using them
06/04/2003EP1315739A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
06/04/2003EP1315707A1 Lipo- or amphiphilic scintillators and their use in assays
06/04/2003EP1315697A1 Herbicidal benzoyl cyclohexane dione
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003CN1422267A Processes for the preparation of thiazolidinedione derivatives and intermediates
06/04/2003CN1110488C 2-(3H)-oxazolene derivatives and their use as cox-2 inhibitors
06/04/2003CN1110487C Process for producing oxazole derivative
06/03/2003USRE38132 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
06/03/2003US6573289 Naphthalene derivatives, their production and use
06/03/2003US6573286 2-(2,6-disubstituted phenyl)-4-aryl-5-alkyl-1,3-oxazoline compounds
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573218 Fused-benzene derivatives useful as herbicides
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003044877A2 Light emitting device and compounds for use therein
05/30/2003WO2003043996A1 A method for preparing of chiral 2,2-dimethylcyclopropanecarboxyl derivatives
05/30/2003WO2003007870A3 Oxazolidinone derivatives as antimicrobials
05/30/2003WO2002094765A3 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
05/29/2003US20030100796 Reacting a 3-oxazolidin-5-one derivative with a halomethyl lithium and then treating with an acid
05/29/2003US20030100776 Allows for substitution of functional groups within the olefin without comprising efficiency of metathesis
05/29/2003US20030100760 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100676 An oxazolidine compound which can be used as a latent curing agent for a moisture curable epoxy or polyepoxide resin
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030100545 Psychological disorder treatments that increase the activity of cholinergic receptors
05/29/2003US20030100441 Polymerization of olefin
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1313719A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/28/2003EP1313717A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313716A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313715A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
05/28/2003CN1420138A UV absorbent for thermoplastic polymer and producing process thereof
05/27/2003US6570039 Process for producing α-aminoketones
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/27/2003US6569884 Conformationally rigid bicyclic and adamantane derivatives useful as α2-adrenergic blocking agents
05/27/2003US6569882 Viricides; enzyme inhibitors
05/22/2003WO2003042194A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003WO2002044144A3 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
05/22/2003US20030096846 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096706 Herbicidal phenoxypropionic acid N-alkyl-N-2-fluorophenyl amide compounds
05/22/2003US20030095985 Immunogenic conjugates of Gram-negative bacterial autoinducer molecules and antibodies raised against the same
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2465861A1 Carboxylic acid derivative compounds and drugs containing the same as the active ingredient
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 210